Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): A cluster-randomised trial

The Lancet

Volumn 378, Issue 9786, 2011, Pages 156-167

  Griffin, Simon J ^a   Borch Johnsen, Knut ^b,c,d   Davies, Melanie J ^e   Khunti, Kamlesh ^e   Rutten, Guy Ehm ^f   Sandbæk, Annelli ^d   Sharp, Stephen J ^a   Simmons, Rebecca K ^a   Van Den Donk, Maureen ^f   Wareham, Nicholas J ^a   Lauritzen, Torsten ^d  

^a INSTITUTE OF METABOLIC SCIENCE   (United Kingdom)

^b STENO DIABETES CENTER   (Denmark)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^d AARHUS UNIVERSITY   (Denmark)

^e UNIVERSITY OF LEICESTER   (United Kingdom)

^f UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; SULFONYLUREA; TRIACYLGLYCEROL;

ADULT; AGED; AMPUTATION; ANGLO DANISH DUTCH STUDY OF INTENSIVE TREATMENT IN PEOPLE WITH DETECTED DIABETES EUROPE; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DENMARK; DIASTOLIC BLOOD PRESSURE; FOLLOW UP; GENERAL PRACTICE; HEART INFARCTION; HUMAN; INTENTION TO TREAT ANALYSIS; MALE; MORBIDITY; MORTALITY; MULTICENTER STUDY; NETHERLANDS; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; RISK REDUCTION; SCREENING; STROKE; SYSTOLIC BLOOD PRESSURE; UNITED KINGDOM;

EID: 79960245269     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(11)60698-3     Document Type: Article

References (41)

1. IDF IDF Diabetes Atlas 4th edn. 2009 International Diabetes Federation Brussels, Belgium
2. P Gaede, P Vedel, N Larsen, GV Jensen, HH Parving, O Pedersen Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes N Engl J Med 348 2003 383 393 (Pubitemid 36159355)
3. P Gaede, H Lund-Andersen, HH Parving, O Pedersen Effect of a multifactorial intervention on mortality in type 2 diabetes N Engl J Med 358 2008 580 591 (Pubitemid 351214285)
4. UK Prospective Diabetes Study Group Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 BMJ 317 1998 703 713
5. Heart Outcomes Prevention Evaluation Study Investigators Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy Lancet 355 2000 253 259
6. K Pyorala, TR Pedersen, J Kjekshus, O Faergeman, AG Olsson, G Thorgeirsson Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S) Diabetes Care 20 1997 614 620 (Pubitemid 27143424)
7. KK Ray, SR Seshasai, S Wijesuriya et al. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials Lancet 373 2009 1765 1772
8. RR Holman, SK Paul, MA Bethel, DR Matthews, HA Neil 10-year follow-up of intensive glucose control in type 2 diabetes N Engl J Med 359 2008 1577 1589
9. MI Harris, R Klein, TA Wellborn, MW Knuiman Onset of NIDDM occurs at least 4-7yr before clinical diagnosis Diabetes Care 15 1992 815 819
10. C Glumer, T Jorgensen, K Borch-Johnsen Prevalences of diabetes and impaired glucose regulation in a Danish population: the Inter99 study Diabetes Care 26 2003 2335 2340 (Pubitemid 36993322)
11. HC Eborall, SJ Griffin, AT Prevost, AL Kinmonth, DP French, S Sutton Psychological impact of screening for type 2 diabetes: controlled trial and comparative study embedded in the ADDITION (Cambridge) randomised controlled trial BMJ 335 2007 486
12. NJ Wareham, SJ Griffin Should we screen for type 2 diabetes? Evaluation against national screening committee criteria BMJ 322 2001 986 988 (Pubitemid 32374692)
13. R Kahn, P Alperin, D Eddy et al. Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis Lancet 375 2010 1365 1374
14. C Glumer, M Yuyun, S Griffin et al. What determines the cost-effectiveness of diabetes screening? Diabetologia 49 2006 1536 1544 (Pubitemid 43848089)
15. T Lauritzen, S Griffin, K Borch-Johnsen, NJ Wareham, BH Wolffenbuttel, G Rutten The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with Type 2 diabetes detected by screening Int J Obes Relat Metab Disord 24 suppl 3 2000 S6 S11
16. JB Echouffo-Tcheugui, RK Simmons, KM Williams et al. The ADDITION-Cambridge trial protocol: a cluster-randomised controlled trial of screening for type 2 diabetes and intensive treatment for screen-detected patients BMC Public Health 9 2009 136
17. DR Webb, K Khunti, B Srinivasan et al. Rationale and design of the ADDITION-Leicester study, a systematic screening programme and randomised controlled trial of multi-factorial cardiovascular risk intervention in people with type 2 diabetes mellitus detected by screening Trials 11 2010 16
18. PG Janssen, KJ Gorter, RP Stolk, GE Rutten Randomised controlled trial of intensive multifactorial treatment for cardiovascular risk in patients with screen-detected type 2 diabetes: 1-year data from the ADDITION Netherlands study Br J Gen Pract 59 2009 43 48
19. A Sandbaek, SJ Griffin, G Rutten et al. Stepwise screening for diabetes identifies people with high but modifiable coronary heart disease risk. The ADDITION study Diabetologia 51 2008 1127 1134
20. LA Sargeant, RK Simmons, RS Barling et al. Who attends a UK diabetes screening programme? Findings from the ADDITION-Cambridge study Diabet Med 27 2010 995 1003
21. WHO Definition, diagnosis, and classification of diabetes mellitus and its complications: report of a WHO consultation 1999 World Health Organization Geneva, Switzerland
22. SJ Griffin, PS Little, CN Hales, AL Kinmonth, NJ Wareham Diabetes risk score: towards earlier detection of Type 2 diabetes in general practice Diabetes Metab Res Rev 16 2000 164 171 (Pubitemid 30410271)
23. C Glumer, B Carstensen, A Sandbaek, T Lauritzen, T Jorgensen, K Borch-Johnsen A Danish diabetes risk score for targeted screening: the Inter99 study Diabetes Care 27 2004 727 733 (Pubitemid 38280541)
24. MJ Davies, S Heller, TC Skinner et al. Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial BMJ 336 2008 491 495 (Pubitemid 351347415)
25. JB Ruige, JN de Neeling, PJ Kostense, LM Bouter, RJ Heine Performance of an NIDDM screening questionnaire based on symptoms and risk factors Diabetes Care 20 1997 491 496 (Pubitemid 27143402)
26. UK Prospective Diabetes Study Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 352 1998 837 853
27. R Collins, J Armitage, S Parish, P Sleigh, R Peto MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial Lancet 361 2003 2005 2016
28. Royal College of General Practitioners in Denmark Type 2-diabetes in general practice - diagnosis and treatment 1999 Royal College of General Practioners Copenhagen, Denmark
29. Royal College of General Practitioners A McIntosh, A Hutchinson, PD Home et al. Clinical guidelines and evidence review for type 2 diabetes: management of blood glucose 2001 University of Sheffield Sheffield, UK
30. GEHM Rutten, S Verhoeven, RJ Heine, WJC De Grauw, PVM Cromme, K Reenders Dutch College of General Practitioners. Practice guideline diabetes mellitus type 2 Huisarts Wetensch 42 1999 67 84
31. IR White, SG Thompson Adjusting for partially missing baseline measurements in randomized trials Stat Med 24 2005 993 1007 (Pubitemid 40426000)
32. TA Gooley, W Leisenring, J Crowley, BE Storer Estimation of failure probabilities in the presence of competing risks: new representations of old estimators Stat Med 18 1999 695 706 (Pubitemid 29126745)
33. C Bradley Handbook of psychology and diabetes: a guide to psychological measurement in diabetes research and practice 1994 Psychology Press London, UK
34. UK Prospective Diabetes Study Group Overview of 6 years' therapy of type II diabetes: a progressive disease Diabetes 44 1995 1249 1258
35. AM Spijkerman, JM Dekker, G Nijpels et al. Impact of diabetes duration and cardiovascular risk factors on mortality in type 2 diabetes: the Hoorn Study Eur J Clin Invest 32 2002 924 930 (Pubitemid 35478064)
36. NF Olivarius, H Beck-Nielsen, AH Andreasen, M Horder, PA Pedersen Randomised controlled trial of structured personal care of type 2 diabetes mellitus BMJ 323 2001 970 975 (Pubitemid 33016046)
37. B Carstensen, J Kristensen, P Ottosen, K Borch-Johnsen The Danish National Diabetes Register: trends in incidence, prevalence and mortality Diabetologia 51 2008 2187 2196
38. T Doran, C Fullwood, H Gravelle et al. Pay-for-performance programs in family practices in the United Kingdom N Engl J Med 355 2006 375 384 (Pubitemid 44127540)
39. Royal College of General Practitioners in Denmark Type 2 diabetes in general practice - an evidence based guideline 2004 Royal College of General Practioners Copenhagen, Denmark
40. GEHM Rutten, WJC de Grauw, G Nijpels et al. Dutch Guidelines on Type 2 Diabetes Mellitus. Dutch College of General Practitioners Huisarts Wetensch 49 2006 137 152
41. M van den Donk, KJ Gorter, GE Rutten No negative effects of a multi-factorial, intensified treatment on self-reported health status, treatment satisfaction, and diabetes-related distress in screen-detected type 2 diabetes patients. The ADDITION-Netherlands study Qual Life Res 19 2010 509 513